Since our transgenic model is representative of the SCL/TAL1 molecular subgroup, we next addressed the question whether these seven HEB target TSGenes would be expressed at lower levels in the TAL1 subgroup compared to the other T-ALL subgroups, using the dataset published by Liu et al. This evidence concerns the gene TAL1 and acute lymphoblastic leukemia.